相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Manufacturing Process Development for Belzutifan, Part 6: Ensuring Scalability for a Deoxyfluorination Reaction
Michael Pirnot et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2022)
Elusive Impurities-Evidence versus Hypothesis. Technical and Regulatory Update on Alkyl Sulfonates in Sulfonic Acid Salts
David J. Snodin
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2019)
Simultaneous Determination of 15 Sulfonate Ester Impurities in Phentolamine Mesylate, Amlodipine Besylate, and Tosufloxacin Tosylate by LC-APCI-MS/MS
Bo Jin et al.
JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY (2019)
Mutagenic Alkyl-Sulfonate Impurities in Sulfonic Acid Salts: Reviewing the Evidence and Challenging Regulatory Perceptions
David Snodin et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2015)
Rapid and simultaneous determination of sulfonate ester genotoxic impurities in drug substance by liquid chromatography coupled to tandem mass spectrometry: Comparison of different ionization modes
Tian Guo et al.
JOURNAL OF CHROMATOGRAPHY A (2014)
Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate Control
Andrew Teasdale et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2013)
Simultaneous determination of alkyl mesilates and alkyl besilates in finished drug products by direct injection GC/MS
Uwe Wollein et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
The Utility of Sulfonate Salts in Drug Development
David P. Elder et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
A Detailed Study of Sulfonate Ester Formation and Solvolysis Reaction Rates and Application toward Establishing Sulfonate Ester Control in Pharmaceutical Manufacturing Processes
Andrew Teasdale et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2010)
Application of Quality by Design Principles to Support Development of a Control Strategy for the Control of Genotoxic Impurities in the Manufacturing Process of a Drug Substance
Zadeo Cimarosti et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2010)
Mechanism and Processing Parameters Affecting the Formation of Methyl Methanesulfonate from Methanol and Methanesulfonic Acid: An Illustrative Example for Sulfonate Ester Impurity Formation
Andrew Teasdale et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2009)
Development and validation of GC-MS method for the determination of methyl methane sulfonate and ethyl methanesulfonate in imatinib mesylate
K. Ramakrishna et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Development and validation of an automated static headspace gas chromatography-mass spectrometry (SHS-GC-MS) method for monitoring the formation of ethyl methane sulfonate from ethanol and methane sulfonic acid
Karine Jacq et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs)
D. P. Elder et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Low level determination of p-toluenesulfonate and benzenesulfonate esters in drug substance by high performance liquid chromatography/mass spectrometry
GE Taylor et al.
JOURNAL OF CHROMATOGRAPHY A (2006)
Determination of methyl and ethyl esters of methanesulfonic, benzenesulfonic and p-toluenesulfonic acids in active pharmaceutical ingredients by solid-phase microextraction (SPME) coupled to GC/SIM-MS
I Colón et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2005)
Structure-activity considerations and in vitro approaches to assess the genotoxicity of 19 methane-, benzene- and toluenesulfonic acid esters
S Glowienke et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2005)